Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Feb 2026, May 2026 and Aug 2026.
- Largest single sale: $89K (1,012 shares) of Dexcom on Aug 12, 2026. Filing
- Last sale before this period: Mar 17, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Dexcom (DXCM) | Director | Sep 17, 2019 | Aug 13, 2026 |
| Merck & Co. (MRK) | Former Exe.VP & Pres.Con.Hlth.Care | May 11, 2010 | May 13, 2014 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 12, 2026, Dexcom: sold 1,012 shares for $89K, under a disclosed plan. 1 filing: 1
- May 28, 2026, Dexcom: 5,575 shares granted. 1 filing: 1
- May 12, 2026, Dexcom: sold 1,012 shares for $61K, under a disclosed plan. 1 filing: 1
- Feb 12, 2026, Dexcom: sold 1,012 shares for $69K, under a disclosed plan. 1 filing: 1
- Nov 12, 2025, Dexcom: sold 1,012 shares for $59K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.